{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-006726","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2022-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.693136+00:00","generated_at":"2026-06-23T01:15:33.165436+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Predictive Oncology appoints tissue law expert David S. Smith to board","bullets":["David S. Smith, JD, elected to Board as Class III director, term expiring at 2024 annual meeting.","Smith fills vacancy created by resignation of Christina Jenkins, M.D. in August 2022.","Smith is a life sciences attorney and authority on legal issues around therapeutic use of human tissue and cells.","Company granted Smith shares of common stock valued at $5,000 under 2012 Stock Incentive Plan.","CEO-elect Raymond Vennare praises Smith's understanding of Predictive Oncology's proprietary biorepository."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-006726","json":"https://secwatch.observer/filing/0001171843-22-006726.json","markdown":"https://secwatch.observer/filing/0001171843-22-006726.md","text":"https://secwatch.observer/filing/0001171843-22-006726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184322006726/0001171843-22-006726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184322006726/f8k_102522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T01:15:33.165436+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8171deb01b","claim":"David S. Smith was elected as Class III director at Axe Compute Inc..","evidence_excerpt":"Effective October 19, 2022, the Board of Directors (“Board”) of Predictive Oncology Inc. (the “Company”) elected David S. Smith, JD, to the Board as a Class III director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446159/000117184322006726/0001171843-22-006726-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}